| Literature DB >> 35247002 |
Loeki Enggar Fitri1,2, Tarina Widaningrum2,3, Agustina Tri Endharti1, Muhammad Hatta Prabowo4, Nuning Winaris1,2, Rivo Yudhinata Brian Nugraha1,2.
Abstract
BACKGROUND: Update diagnostic methods play essential roles in dealing with the current global malaria situation and decreasing malaria incidence. AIM: Global malaria control programs require the availability of adequate laboratory tests in the quick and convenient field.Entities:
Keywords: LAMP; Malaria; PCR; POCT; RDT; diagnostic
Mesh:
Year: 2022 PMID: 35247002 PMCID: PMC8993657 DOI: 10.1002/jcla.24314
Source DB: PubMed Journal: J Clin Lab Anal ISSN: 0887-8013 Impact factor: 2.352
Comparison among microscopy method, RDT, and PCR
| Parameters | Microscopy | RDT | PCR |
|---|---|---|---|
| Principle techniques | Morphologic interpretation | Antigen and antibody binding | DNA amplification |
| Target diagnostic | All stages of the parasite (early trophozoite, mature trophozoite, schizont, and gametocyte) |
| Small subunit rRNA/ssrRNA, SICAvar gene |
| Sensitivity | Up to 5 parasites/μl (the expert microscopist) 50–100 parasites/μl (the average microscopist) | 50–250 parasites/μl | Below five parasites/μl |
| Specificity | High (unless for | Moderate (limited to | High, can identify and differentiate among species |
| Time consume | Up to 60 min | 10–20 min | 2–8 h |
| Interpretation | Quantitative | Qualitative | Quantitative and qualitative |
| Advantages | Low direct cost. can be stored for a long time | Simple, fast, more practical, and applicable method | Requiring only a small sample |
| Disadvantages | Need special equipment and well‐trained technicians | Cannot use for drug monitoring, more expensive | Supply costs, machinery fees, and training expenses |
List of primers used in various nucleic acid amplification tests
| Method | Primer name | Sequence (5′ to 3′) | Specificity | Size (bp) |
|---|---|---|---|---|
| Nested PCR | rPLU1 | TCAAAGATTAAGCCATGCAAGTGA |
| 1600–1700 bp |
| rPLU5 | CCTGTTGTTGCCTTAAACTCC | |||
| rPLU5 | CCTGTTGTTGCCTTAAACTCC |
| 1200 bp | |
| rPLU6 | TTAAAATTGTTGCAGTTAAAACG | |||
| rPLU3 | TTTTTATAAGGATAACTACGGAAAAGCTGT |
| 235 bp | |
| rPLU4 | TACCCGTCATAGCCATGTTAGGCCAATACC | |||
| rVIV1 | CGCTTCTAGCTTAATCCACATAACTGATAC |
| 120–121 bp | |
| rVIV2 | ACTTCCAAGCCGAAGCAAAGAAAGTCCTTA | |||
| rFAL1 | TTAAACTGGTTTGGGAAAACCAAATATATT |
| 205–206 bp | |
| rFAL2 | ACACAATGAACTCAATCATGACTACCCGTC | |||
| rMAL1 | ATAACATAGTTGTACGTTAAGAATAACCGC |
| 144–145 bp | |
| rMAL2 | AAAATTCCCATGCATAAAAAATTATACAAA | |||
| rOVA1 | ATCTCTTTTGCTATTTTTTAGTATTGGAGA |
| approx. 800 bp | |
| rOVA2 | GGAAAAGGACACATTAATTGTATCCTAGTG | |||
| rOVA1 | ATCTCTTTTGCTATTTTTTAGTATTGGAGA |
| 226 bp | |
| rPLU2 | AGAATTTCACCTCTGACATCTG | |||
| Nested PCR | rPLU1 | TCAAAGATTAAGCCATGCAAGTGA |
| 1600–1700 bp |
| rPLU5 | CCTGTTGTTGCCTTAAACTCC | |||
| Pmk8 | GTTAGCGAGAGCCACAAAAAAGCGAA |
| 153 bp | |
| Pmkr9 | ACTCAAAGTAACAAAATCTTC CGTA | |||
| Nested and semi‐nested PCR | PkF1140 | GATTCATCTATTAAAAATTGCTTC |
| 410 bp |
| PkR1550 | CTTTTCTCTCCGGAGATTAGAACTC | |||
| PkF1160 | GATGCCTCCGCGTATCGAC |
| 498 bp | |
| PkR1550 | CTTTTCTCTCCGGAGATTAGAACTC | |||
| Heminested PCR | SICAf1 | 5′‐GGTCCTCTTGGTAAAGGAGG‐3′ |
| 228–249 bp |
| SICAr1 | 5′‐CCCTTTTTGACATTCGTCC‐3′; | |||
| SICAf2 | 5′‐CTTGGTAAAGGAGGACCACG‐3′ | |||
| SICAr1 | 5′‐CCCTTTTTGACATTCGTCC‐3′; | |||
| Multiplex PCR | UNR | GACGGTATCTGATCGTCTTTC | Universal | Position 1229 on the published sequence X03205 for human 18srRNA |
| PLF | AGTGTGTATCAATCGAGTTTC |
| 787 bp | |
| FAR | AGTTCCCCTAGAATAGTTACA |
| 395 bp | |
| VIR | AGGACTTCCAAGCCGAAGC |
| 499 bp | |
| LAMP | F3 | TGTAATTGGAATGATAGGAATTTA |
| – |
| B3 | GAAAACCTTATTTTGAACAAAGC | |||
| FIP (F1c‐F2) | AGCTGGAATTACCGCGGCTGGGTTCCTAGAGAAACAATTGG | |||
| BIP (B1‐B2c) | TGTTGCAGTTAAAACGTTCGTAGCCCAAACCAGTTTAAATGAAAC | |||
| Loop F | GCACCAGACTTGCCCT | |||
| Loop B | TTGAATATTAAAGAA |
List of primers used in RPA methods
| Specificity | Primer name | Sequence (5′ to 3′) |
|---|---|---|
|
| Forward | 5′‐CACGAACTAAAAACGGCCATGCATCACCATCC‐3′ |
| Reverse | 5′‐biotin‐CCTTATGAGAAATCAAAGTCTTTGGGTTCTGGGG‐3′ | |
| Probe | 5′‐FAM‐ATCAAGAAAGAGCTATTAATCTGTCAATCCTAC‐THF‐CTTGTCTTAAACTAGTG‐3′ | |
|
| Forward | 5′‐CATGGCTATGACGGGTAACGGGGAATTAGA‐3′ |
| Reverse | 5′ digoxigenin‐AATTGGGTAATTTACGCGCCTGCTGCCTTC‐3′ | |
| Probe | 5′‐FAM‐CATGGCTATGACGGGTAACGGGGAATTAGA‐THF‐TTCGATTCCGGAGAG‐3′ | |
|
| Forward | 5′‐CCGTTCTCATGATTTCCATGGTCCAGGGTT‐3′ |
| Reverse | 5′‐biotin‐CCTGAACACCTCATGTCGTGGTAGAAATAG‐3′ | |
| Probe | 5′‐FAM‐CCGTTCTCATGATTTCCATGGTCCAGGGTT‐THF‐AGTTTTTTCGGTCCC‐3′ | |
|
| Forward | 5′‐GTGTTCATAACAGACGGGTAGTCATGATTGAGT‐3′ |
| Reverse | 5′‐digoxigenin‐ACATCTGAATACGAATGCCCCCAAAGATACTCC‐3′ | |
| Probe | 5′‐FAM‐GTGTTTGAATACTACAGCATGGAATAACAA‐THF‐TATGAATAAGCTAATTATT‐3′ |